Quebec City is currently hosting the annual meeting of the International Vaccine Society, which is being held at the Center de Congrès de Québec.
• Read also: Soon the end of the pandemic, according to the boss of the WHO
• Read also: European regulator authorizes bivalent Pfizer vaccine once morest Omicron subvariants
• Read also: Pfizer’s vaccine licensed for children six months and older
Since this morning, conferences have been held on the future of vaccines, including those once morest COVID-19, monkeypox and HIV.
22 countries are represented for the event, such as Canada, the United States, Mexico and Japan.
Messenger RNA vaccines are widely known due to the COVID-19 pandemic, but researchers at the conference have been discussing this innovative technology for more than six years.
The event has been postponed for two years in a row, but the co-president of theInternational Society for Vaccines sees the thing with a good eye.
“The big advantage of having delayed the event for two years is that during this time, the vaccination did some good. We can look forward with the new technologies that are available. It’s really fantastic,” says Gary Kobinger.
An Australian researcher present for the occasion explains the advances made for vaccines that adapt to new variants of COVID-19.
“We are trying to make vaccines that will fight the variants,” says Makutiro Masavuli, a student at the University of Adelaide.
